Published 24 hours ago • loading... • Updated 2 hours ago
Hims & Hers Health (NYSE:HIMS) Stock Price Down 7.3% - What's Next?
Summary by MarketBeat
4 Articles
4 Articles
Will HIMS Q3 Earnings Tonight Spark a Rebound After Today's 10% Selloff?
A blockbuster Eli Lilly partnership landed days before the report, yet the stock still slid. Hims & Hers now faces a margin problem that could decide whether its weight-loss gamble pays off or backfires.
Coverage Details
Total News Sources4
Leaning Left0Leaning Right0Center2Last Updated100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium









